Definitive Healthcare (NASDAQ:DH) Now Covered by Analysts at Stephens

Stephens started coverage on shares of Definitive Healthcare (NASDAQ:DH) in a report published on Friday, MarketBeat.com reports. The firm issued an equal weight rating and a $5.00 target price on the stock.

DH has been the subject of several other reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. BTIG Research initiated coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target for the company. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $5.72.

Definitive Healthcare Trading Up 1.0 %

NASDAQ DH opened at $4.18 on Friday. Definitive Healthcare has a one year low of $3.19 and a one year high of $10.62. The firm has a market cap of $482.89 million, a PE ratio of -1.35, a P/E/G ratio of 3.29 and a beta of 1.40. The firm’s fifty day moving average is $4.41 and its two-hundred day moving average is $4.69. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49.

Insider Buying and Selling at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 14.84% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Definitive Healthcare

Several hedge funds have recently bought and sold shares of DH. 272 Capital LP grew its stake in Definitive Healthcare by 74.8% in the 3rd quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after acquiring an additional 476,766 shares during the last quarter. Barclays PLC lifted its holdings in shares of Definitive Healthcare by 318.8% in the third quarter. Barclays PLC now owns 81,916 shares of the company’s stock valued at $366,000 after purchasing an additional 62,354 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Definitive Healthcare in the third quarter valued at approximately $93,000. State Street Corp increased its stake in shares of Definitive Healthcare by 29.4% during the 3rd quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after purchasing an additional 317,952 shares in the last quarter. Finally, Point72 DIFC Ltd raised its position in shares of Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after purchasing an additional 8,215 shares during the last quarter. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.